bioRxivImmunologyPreprint
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection
J. M. Dan, J. Mateus, Y. Kato, K. M. Hastie, E. D. Yu, C. Faliti, A. Grifoni, S. I. Ramirez, S. Haupt, A. Frazier, C. Nakao, V. Rayaprolu, S. A. Rawlings, B. Peters, F. Krammer, V. Simon, E. O. Saphire, D. Smith, D. Weiskopf, A. Sette, S. Crotty
Abstract
Understanding immune memory to SARS-CoV-2 is critical for improving diagnostics and vaccines, and for assessing the likely future course of the COVID-19 pandemic. We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 254 samples from 188 COVID-19 cases, including 43 samples at [≥] 6 months post-infection. IgG to the Spike protein was relatively stable over 6+ months. Spike-specific memory B cells were more abundant at 6 months than at 1 month post symptom onset. SARS-CoV-2-specific CD4+ T cells and CD8+ T cells declined with a half-life of 3-5 months. By studying antibody, memory B cell, CD4+ T cell, and CD8+ T cell memory to SARS-CoV-2 in an integrated manner, we observed that each component of SARS-CoV-2 immune memory exhibited distinct kinetics.
- organism: human
- assay: proteomics
- assay: flow cytometry
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
S. P. Anand, J. Prevost, … A. Finzi·bioRxiv·Jan 25, 2021
- SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individuals
- Immunity to SARS-CoV-2 up to 15 months after infection
H. Marcotte, A. Piralla, … Q. Pan-Hammarstrom·bioRxiv·Oct 8, 2021
- Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection
N. Sherina, A. Piralla, … Q. Pan-Hammarstrom·bioRxiv·Nov 6, 2020
- Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infection
J. T. Sandberg, R. Varnaite, … S. Gredmark-Russ·bioRxiv·Mar 17, 2021
- Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection